Health

Breakthrough in Aquaculture: Mycelium Significantly Lowers Salmon Mortality Rates

2025-03-18

Author: Siti

Revolutionizing Aquaculture

In an exciting new study conducted in Prince Edward Island, researchers from Onda have unveiled promising results that could revolutionize the aquaculture industry.

The MycoFence Study

Atlantic salmon, a popular choice for consumers and a staple in seafood markets, were the focus of a challenge trial where they were fed varying concentrations of a novel product called MycoFence, derived from mycelium.

Remarkable Findings

The findings were remarkable: salmon that received higher doses of MycoFence exhibited a significantly lower mortality rate compared to those in a control group that did not receive any β-glucan supplementation.

This suggests that MycoFence has a powerful immunostimulatory effect, which could pave the way for reducing antibiotic use in fish farms – a critical issue given the growing concern over antibiotic resistance in both aquatic and terrestrial environments.

Citribel: Innovators in Biotech

MycoFence is the brainchild of Citribel, a Belgian biotech innovator known for harnessing advanced technologies to convert fungal biomass into valuable ingredients.

Citribel's focus on sustainability and efficiency positions them as leaders in producing alternative products that not only support better health in fish but also strive to protect the environment.

Looking Ahead

This breakthrough could not only enhance fish health and welfare but may also lead to a cleaner, safer aquaculture system, making it an important step forward in meeting global food demands sustainably.

The results invite optimism not only for salmon farmers but for the entire aquaculture sector facing challenges from disease management and environmental concerns.

Conclusion

Stay tuned as more research emerges, and don’t miss the opportunity to learn how innovations like MycoFence could reshape the future of sustainable aquaculture!